The Anabolic Dex compound index

Long-acting testosterone ester; the most common TRT and cycle base. Reaches steady state in ~5 weeks.

Half-life: 7d
Typical: 100.0 mg–600.0 mg

Testosterone Cypionate

Test Cyp, TC

Standard US TRT ester with a slightly longer release tail than enanthate. Steady state ~4–5 weeks.

Half-life: 7d
Typical: 100.0 mg–600.0 mg

Testosterone Propionate

Test P, TP

Short-acting ester with sharp peaks; requires frequent injection. Useful for frontloading.

Half-life: 2d
Typical: 50.0 mg–150.0 mg

Testosterone Undecanoate (Castor Oil)

Nebido, TU, Reandron

Very long-acting ester (Nebido). Dosed 1000 mg every 10–14 weeks for TRT. NHS standard.

Half-life: 34d
Typical: 750.0 mg–1000.0 mg

Testosterone Undecanoate (MCT Oil)

TU MCT, Testosterone Undecanoate

MCT-carried testosterone undecanoate; shorter apparent half-life than the castor-oil formulation.

Half-life: 20d
Typical: 500.0 mg–1000.0 mg

Testosterone Undecanoate (Oral)

Jatenzo, Andriol, Oral TU

Oral testosterone (Jatenzo/Andriol) with low lymphatic bioavailability; dosed twice daily with food.

Half-life: 0.8d
Typical: 158.0 mg–396.0 mg

AromatizesHepato: mild

Testosterone Phenylpropionate

Test PP

Medium-chain ester (Sustanon component). Simple model — peak calibrated from sibling esters.

Half-life: 3d
Typical: 50.0 mg–200.0 mg

Testosterone Isocaproate

Test Iso

Sustanon component with medium duration. Simple model — peak calibrated from sibling esters.

Half-life: 3d
Typical: 50.0 mg–200.0 mg

Testosterone Suspension

Test Base (injectable), Aquadose

Ester-free injectable testosterone (water base). Very sharp peaks; dosed daily.

Half-life: 1d
Typical: 25.0 mg–100.0 mg

Testosterone Decanoate

Test Deca

Long-chain ester (Sustanon component). Simple model.

Half-life: 6d
Typical: 100.0 mg–300.0 mg

Testosterone Gel (Testogel/AndroGel)

Testogel, AndroGel, Transdermal T

Transdermal testosterone gel providing steady low-level delivery. Transfer risk to others.

Half-life: 3d
Typical: 25.0 mg–100.0 mg

Testosterone Base (Sublingual)

Sublingual T, Testoplek

Sublingual testosterone with extremely rapid peak and clearance; dosed multiple times daily.

Half-life: 0.0d
Typical: 12.5 mg–50.0 mg

Boldenone Cypionate

EQ Cyp

Boldenone with a cypionate ester. Model inherited from testosterone cypionate — treat as approximate.

Half-life: 7d
Typical: 150.0 mg–400.0 mg

Trenbolone Enanthate

Tren E

Long-acting 19-nor injectable; potent androgen with no aromatization. Simple model — peak calibrated.

Half-life: 11d
Typical: 150.0 mg–400.0 mg

Trenbolone Acetate

Tren A, Fina

Short-acting 19-nor ester requiring every-other-day dosing. Simple model — peak calibrated.

Half-life: 2d
Typical: 35.0 mg–100.0 mg

Trenbolone Hexahydrobenzylcarbonate

Tren Hex, Parabolan

Long-acting trenbolone (original Parabolan). Simple model — peak calibrated.

Half-life: 8d
Typical: 100.0 mg–300.0 mg

Trestolone Acetate (MENT)

MENT, Trest A

7α-methyl-19-nortestosterone acetate; potent, aromatizing, investigational male contraceptive.

Half-life: 0.2d
Typical: 10.0 mg–50.0 mg

AromatizesHepato: mild

Masteron Propionate

Drostanolone Prop, Mast P

DHT-derived drostanolone propionate; anti-estrogenic, cutting agent. Simple model — peak calibrated.

Half-life: 2d
Typical: 50.0 mg–150.0 mg

DHT

Masteron Enanthate

Drostanolone Enth, Mast E

Longer-acting drostanolone ester. Simple model — peak calibrated.

Half-life: 8d
Typical: 200.0 mg–400.0 mg

DHT

Mesterolone (Proviron)

Proviron

Oral DHT derivative; low bioavailability, used for SHBG binding / anti-estrogenic effect.

Half-life: 0.5d
Typical: 25.0 mg–100.0 mg

Nandrolone Phenylpropionate

NPP, Durabolin

Short-acting 19-nor (NPP); faster clearance than Deca. Good for frontloading.

Half-life: 2d
Typical: 50.0 mg–200.0 mg

Nandrolone Decanoate

Deca, Nandrolone Deca

Long-acting 19-nor (Deca-Durabolin); collagen/joint benefits, very long clearance.

Half-life: 10d
Typical: 100.0 mg–400.0 mg

Boldenone Undecylenate (Equipoise)

EQ, Equipoise, Boldenone

Equipoise; long half-life, slow steady gains. Notorious for long detection times.

Half-life: 14d
Typical: 200.0 mg–600.0 mg

Dihydroboldenone (DHB)

DHB, 1-Testosterone Cypionate

1-testosterone (DHB); potent, non-aromatizing. Limited human PK data.

Half-life: 9d
Typical: 100.0 mg–300.0 mg

Primobolan (Oral)

Methenolone Acetate, Primo Oral

Oral methenolone acetate; mild, low-side, short half-life. Simple model — peak calibrated.

Half-life: 0.2d
Typical: 25.0 mg–100.0 mg

Primobolan (Injectable)

Methenolone Enanthate, Primo

Injectable methenolone enanthate; very long half-life, mild profile. Peak calibrated.

Half-life: 11d
Typical: 200.0 mg–400.0 mg

DHT

Halotestin

Fluoxymesterone, Halo

Extremely hepatotoxic oral; pure strength/aggression, minimal hypertrophy.

Half-life: 0.1d
Typical: 5.00 mg–30.0 mg

DHTHepato: severe

Anadrol

Oxymetholone, A50, Drol

AromatizesDHTHepato: severe

Potent oral mass builder; high water retention and significant hepatotoxicity.

Half-life: 0.3d
Typical: 25.0 mg–100.0 mg

Dianabol

Methandrostenolone, Dbol, Methandienone

AromatizesHepato: moderate

Classic oral mass builder; short half-life, strong aromatization. Simple model — peak calibrated.

Half-life: 0.2d
Typical: 15.0 mg–50.0 mg

Turinabol

4-Chlorodehydromethyltestosterone, Tbol

Oral cross between Dbol and Clostebol; low water retention, moderate liver toxicity. Peak calibrated.

Half-life: 0.7d
Typical: 20.0 mg–60.0 mg

Hepato: moderate

Winstrol (Oral)

Stanozolol, Winny

Oral stanozolol; cutting agent, joint pain common. Simple model — peak calibrated.

Half-life: 0.4d
Typical: 20.0 mg–50.0 mg

DHTHepato: moderate

Winstrol (Injectable)

Winstrol Depot, Stanozolol Inj

Injectable stanozolol suspension; micro-crystals give a long apparent peak.

Half-life: 3d
Typical: 50.0 mg–100.0 mg

Anavar

Oxandrolone, Var

Mild oral oxandrolone; favored in cutting and female use due to low androgenicity.

Half-life: 0.4d
Typical: 10.0 mg–50.0 mg

Superdrol

Methasterone

Design steroid methasterone; notorious for severe hepatotoxicity. Simple model — peak calibrated.

Half-life: 0.4d
Typical: 10.0 mg–30.0 mg

DHTHepato: severe

SARMs

Ostarine (MK-2866 / Enobosarm)

MK-2866, Enobosarm

Non-steroidal SARM; mild, used in cutting/recomp. Simple model (estimated).

Half-life: 1d
Typical: 10.0 mg–25.0 mg

Ligandrol (LGD-4033)

LGD-4033, LGD, Anabolicum

Potent SARM for lean mass; suppression evident at higher doses.

Half-life: 1d
Typical: 2.00 mg–10.0 mg

Andarine (S4)

S4, Andarine

SARM with notable vision-related side effects; short half-life requiring divided dosing.

Half-life: 0.2d
Typical: 12.5 mg–50.0 mg

Testolone (RAD-140)

RAD-140, RAD

Potent SARM; suppression and hepatotoxicity reported at higher doses.

Half-life: 2d
Typical: 5.00 mg–20.0 mg

Cardarine (GW-501516)

GW-501516, GW, Endurobol

PPARδ agonist (mislabeled as SARM); improves endurance. Not a hormone.

Half-life: 0.8d
Typical: 5.00 mg–20.0 mg

S-23

S23

Suppressive SARM explored for male contraception; short half-life.

Half-life: 0.2d
Typical: 5.00 mg–30.0 mg

Pharmaceuticals/Chemicals

Estradiol Topical (EstroGel)

EstroGel, E2 Gel

Transdermal estradiol for feminizing HRT. Steady low-level delivery.

Half-life: 2d
Typical: 500 mcg–1.50 mg

Estradiol Cypionate

E2 Cyp, Depo-Estradiol

Injectable estradiol cypionate used in feminizing HRT.

Half-life: 4d
Typical: 2.00 mg–10.0 mg

Estradiol Valerate

E2V, Progynon

Injectable estradiol valerate, common in feminizing HRT. Simple model.

Half-life: 4d
Typical: 2.00 mg–10.0 mg

Progesterone (Oral)

Prometrium, Oral P4

Micronized oral progesterone; short half-life with high first-pass metabolism.

Half-life: 0.9d
Typical: 100.0 mg–300.0 mg

Progesterone (Vaginal)

Vaginal P4

Vaginal micronized progesterone; bypasses much first-pass metabolism.

Half-life: 0.9d
Typical: 100.0 mg–400.0 mg

T3 (Triiodothyronine)

Liothyronine, Cytomel, T3

Liothyronine (T3); short half-life requiring divided dosing.

Half-life: 0.9d
Typical: 25 mcg–75 mcg

DNP

2,4-Dinitrophenol

Industrial mitochondrial uncoupler; extremely hazardous with documented fatalities. For harm-reduction reference only.

Half-life: 4d
Typical: 50.0 mg–200.0 mg

Hepato: severe

Arimidex (Anastrozole)

Anastrozole, Adex, AI

Non-steroidal aromatase inhibitor; used to control estradiol on-cycle. Over-suppression risk.

Half-life: 2d
Typical: 250 mcg–1.00 mg

Aromasin (Exemestane)

Exemestane, Exe, Suicidal AI

Steroidal (suicidal) aromatase inhibitor; permanently inactivates aromatase enzyme.

Half-life: 0.9d
Typical: 6.25 mg–25.0 mg

Clenbuterol (Oral)

Clen

β2-agonist bronchodilator used off-label for fat loss; cardiac stimulation risk.

Half-life: 1d
Typical: 20 mcg–120 mcg

Nolvadex (Tamoxifen)

Tamoxifen, Nolva, SERM

SERM used in PCT and on-cycle gynecomastia management. Active metabolite endoxifen.

Half-life: 2d
Typical: 10.0 mg–40.0 mg

Clomid (Clomiphene)

Clomiphene, Clomid, SERM

SERM that blocks hypothalamic estrogen receptors, boosting LH/FSH; primary PCT agent.

Half-life: 5d
Typical: 25.0 mg–100.0 mg

Cabergoline

Caber, Dostinex

Dopamine D2 agonist used to manage prolactin elevation (e.g. on 19-nors).

Half-life: 4d
Typical: 125 mcg–1.00 mg

Letrozole

Letro, Femara

Potent non-steroidal AI; highest estrogen suppression of the three common AIs.

Half-life: 1d
Typical: 625 mcg–2.50 mg

Nebivolol

Bystolic

β1-selective blocker with nitric-oxide-mediated vasodilation; BP management on-cycle.

Half-life: 0.7d
Typical: 2.50 mg–20.0 mg

Telmisartan

Micardis

Angiotensin II receptor blocker; PPAR-γ activity may improve lipid profile on-cycle.

Half-life: 1.0d
Typical: 20.0 mg–80.0 mg

Tadalafil

Cialis

Long-acting PDE5 inhibitor; also used off-cycle for BPH/endothelial support.

Half-life: 0.7d
Typical: 2.50 mg–20.0 mg

Peptides

HCG

Human Chorionic Gonadotropin, Choragon

Human chorionic gonadotropin; mimics LH, used on-cycle and in PCT to preserve testicular function.

Hormone SupportPCT

Half-life: 2d
Typical: 250 mcg–1.00 mg

Human Growth Hormone (HGH)

HGH, Somatropin, GH

Muscle BuildingRecovery & HealingAnti-Aging & Longevity

Recombinant growth hormone; supports lipolysis, recovery, IGF-1 elevation.

Half-life: 0.2d
Typical: 500 mcg–4.00 mg

Semaglutide Injection (Ozempic/Wegovy)

Ozempic, Wegovy, Sema

Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.

Half-life: 7d
Typical: 250 mcg–2.40 mg

Semaglutide Oral (Rybelsus)

Rybelsus, Oral Sema

Oral semaglutide with very low bioavailability; taken fasting.

Half-life: 0.5d
Typical: 3.00 mg–14.0 mg

Tirzepatide (Mounjaro)

Mounjaro, Tirz, Zepbound

Dual GIP/GLP-1 agonist for weight loss and diabetes; weekly injection, strong efficacy.

Half-life: 5d
Typical: 2.50 mg–15.0 mg

Retatrutide

Reta, Triple-G

Triple-agonist (GLP-1/GIP/glucagon) investigational peptide; very potent weight loss.

Half-life: 6d
Typical: 1.00 mg–12.0 mg

Mazdutide

Maz, GLP-1/GCG

GLP-1/glucagon dual agonist; long half-life, weekly dosing.

Half-life: 18d
Typical: 3.00 mg–9.00 mg

Cagrilintide

Cagri

Long-acting calcitonin/amylin analog used with semaglutide (CagriSema) for obesity; weekly injection.

Half-life: 7d
Typical: 160 mcg–2.40 mg

Dulaglutide (Trulicity)

Trulicity, Dula

Long-acting GLP-1 agonist for type 2 diabetes and weight loss; weekly subcutaneous injection.

Half-life: 5d
Typical: 750 mcg–4.50 mg

Pramlintide (Symlin)

Symlin

Synthetic amylin analog used at mealtimes to slow gastric emptying and aid glycemic/weight control.

Half-life: 0.0d
Typical: 15 mcg–120 mcg

Survodutide

Survodu, BI 456906

Investigational dual GLP-1/glucagon receptor agonist for obesity and MASH; weekly injection.

Half-life: 6d
Typical: 720 mcg–9.60 mg

5-Amino-1MQ

5-amino-1MQ, 1MQ, 5-Amino-1-methylquinolinium

Small-molecule NNMT inhibitor investigated for fat loss and metabolic research; limited human data.

Half-life: 0.5d
Typical: 25.0 mg–100.0 mg

Adipotide

FTP peptide

Experimental peptide that targets the blood supply of white fat; research-stage, notable risks.

Weight Loss

Half-life: 0.0d
Typical: 1.00 mg–5.00 mg

HGH Fragment 176-191 (AOD-9604)

AOD-9604, HGH Frag, AOD9604, Fragment 176-191

Modified fragment of the growth hormone C-terminus studied for lipolysis without growth effects.

Weight Loss

Half-life: 0.5d
Typical: 250 mcg–1.00 mg

MGF (Mechano Growth Factor)

MGF, IGF-1Ec

Muscle BuildingRecovery & Healing

IGF-1 splice variant produced in response to mechanical load; involved in muscle repair signaling.

Half-life: 0.0d
Typical: 200 mcg–800 mcg

PEG-MGF (Pegylated MGF)

PEG-MGF

Muscle BuildingRecovery & Healing

Pegylated mechano growth factor with extended half-life versus native MGF; used for recovery research.

Half-life: 0.8d
Typical: 200 mcg–800 mcg

IGF-1 DES

Des(1-3) IGF-1, IGF-DES

Truncated, highly potent IGF-1 variant with very short half-life; site-injection research compound.

Muscle Building

Half-life: 0.0d
Typical: 25 mcg–100 mcg

IGF-1 LR3

Long R3 IGF-1, LR3

Long-acting IGF-1 analog engineered to resist binding proteins; muscle-growth research compound.

Muscle Building

Half-life: 0.5d
Typical: 20 mcg–100 mcg

CJC-1295 with DAC

CJC-1295 DAC, Drug Affinity Complex

Long-acting GHRH analog with a drug-affinity complex that extends half-life to ~6–8 days; weekly dosing.

Half-life: 8d
Typical: 1.00 mg–3.00 mg

CJC-1295 without DAC (Modified GRF 1-29)

Mod GRF 1-29, CJC-1295 NO DAC, CJC no DAC

Short-acting GHRH analog (~30 min half-life) usually paired with a GHRP for pulsatile GH release.

Half-life: 0.0d
Typical: 100 mcg–500 mcg

Ipamorelin

Selective GHRP secretagogue releasing growth hormone with relatively minimal cortisol/prolactin effect.

Half-life: 0.1d
Typical: 100 mcg–500 mcg

Sermorelin

GRF 1-29

Hormone SupportAnti-Aging & Longevity

Bioidentical GHRH fragment used diagnostically and off-label to stimulate endogenous growth hormone.

Half-life: 0.0d
Typical: 150 mcg–500 mcg

Tesamorelin

Egrifta

Hormone SupportMuscle BuildingWeight Loss

N-terminally stabilized GHRH analog approved to reduce excess visceral fat in HIV lipodystrophy.

Half-life: 0.0d
Typical: 1.00 mg–2.00 mg

GHRP-2

Pralmorelin, GHRP2

Growth hormone secretagogue that acts on the ghrelin receptor to amplify GH pulses.

Half-life: 0.0d
Typical: 100 mcg–300 mcg

GHRP-6

GHRP6

Ghrelin-receptor secretagogue that increases GH and notably stimulates appetite.

Half-life: 0.0d
Typical: 100 mcg–300 mcg

MK-677 (Ibutamoren)

Ibutamoren, MK677, MK 677, Nutrobal

Muscle BuildingRecovery & HealingAnti-Aging & Longevity

Orally active growth hormone secretagogue (ghrelin receptor agonist) that elevates GH and IGF-1; the non-peptide counterpart to injectable GHRPs.

Half-life: 0.2d
Typical: 10.0 mg–25.0 mg

ACE-031

ActRIIb-Fc

Investigational decoy receptor that sequesters myostatin/GDF-11 to drive muscle growth.

Muscle BuildingMetabolic

Half-life: 3d
Typical: 500 mcg–3.00 mg

AICAR

Acadesine, 5-Aminoimidazole-4-carboxamide ribonucleotide

AMPK-activating nucleotide studied as an exercise mimetic for endurance and metabolic research.

MetabolicMuscle Building

Half-life: 0.2d
Typical: 10.0 mg–50.0 mg

EPO (Erythropoietin)

Erythropoietin, Epoetin, EPO

Recombinant erythropoietin that stimulates red blood cell production; used clinically and abused for endurance.

Muscle BuildingMetabolic

Half-life: 0.4d
Typical: 5 mcg–20 mcg

HMG (Menotropin)

Human Menopausal Gonadotropin, Menotropin, Menopur

Human menopausal gonadotropin providing FSH and LH activity; used in PCT and fertility protocols.

Hormone SupportPCT

Half-life: 2d
Typical: 75 mcg–300 mcg

Gonadorelin Acetate

GnRH, LHRH

Native gonadotropin-releasing hormone; stimulates LH/FSH release. Pulsatile (not continuous) use matters.

Hormone Support

Half-life: 0.0d
Typical: 50 mcg–500 mcg

Kisspeptin

Kisspeptin-10, Metastin

Neuropeptide that drives GnRH release upstream of the HPG axis; researched for hormone restoration.

Hormone Support

Half-life: 0.0d
Typical: 250 mcg–1.00 mg

BPC-157

Body Protection Compound

Gastric-derived peptide widely used off-label for tendon, ligament, and gut healing research.

Half-life: 0.2d
Typical: 250 mcg–1.00 mg

TB-500 (Thymosin Beta-4)

Thymosin β4, TB500, Thymosin Beta-4 Acetate

Synthetic version of thymosin beta-4 involved in tissue repair, angiogenesis, and recovery.

Half-life: 0.1d
Typical: 250 mcg–2.50 mg

TB-500 Fragment

TB-500 (FRAG), LKKTETQ

Short active fragment of thymosin beta-4 intended to retain the healing motif with faster clearance.

Half-life: 0.0d
Typical: 100 mcg–500 mcg

Thymosin Alpha-1

Tα1, Thymalfasin, Zadaxin

Immune SupportRecovery & Healing

Thymic peptide that modulates innate and adaptive immunity; used clinically in some viral hepatitis settings.

Half-life: 0.1d
Typical: 800 mcg–3.20 mg

ARA-290 (Cibinetide)

Cibinetide

Recovery & HealingImmune Support

Peptide analog of the erythropoietin helix B region studied for neuropathy and tissue protection.

Half-life: 0.5d
Typical: 2.00 mg–8.00 mg

SS-31 (Elamipretide)

Elamipretide, Bendavia

Recovery & HealingMetabolic

Mitochondria-targeted peptide that stabilizes cardiolipin; researched for metabolic and renal disease.

Half-life: 0.1d
Typical: 2.00 mg–8.00 mg

MOTS-c

Mitochondrial-derived peptide

Mitochondrial-derived peptide that regulates metabolic homeostasis and AMPK signaling.

MetabolicWeight Loss

Half-life: 0.5d
Typical: 2.50 mg–10.0 mg

Dermorphin

Potent amphibian-derived opioid peptide; research compound for analgesia.

Half-life: 0.0d
Typical: 5 mcg–20 mcg

Cerebrolysin

CognitiveRecovery & Healing

Mixture of low-molecular-weight neuropeptides and amino acids researched for stroke and cognitive recovery.

Half-life: 0.0d
Typical: 1.00 mg–10.0 mg

Cartalax

Anti-Aging & LongevityRecovery & Healing

Peptide bioregulator researched for cartilage and joint tissue support.

Half-life: 0.2d
Typical: 500 mcg–2.00 mg

Prostamax

Anti-Aging & LongevityHormone Support

Peptide bioregulator researched for prostate tissue support.

Half-life: 0.2d
Typical: 500 mcg–2.00 mg

Testagen

Anti-Aging & LongevityHormone SupportMuscle Building

Peptide bioregulator researched for testicular function and hormonal support.

Half-life: 0.2d
Typical: 500 mcg–2.00 mg

Vesugen

Anti-Aging & LongevityRecovery & Healing

Peptide bioregulator researched for vascular wall and cardiovascular support.

Half-life: 0.2d
Typical: 500 mcg–2.00 mg

L-Carnitine (Injectable)

Levocarnitine, Carnitine

Amino-acid-derived compound involved in fatty-acid transport; injectable form used in "Lipo" mixes.

MetabolicWeight Loss

Half-life: 0.6d
Typical: 50.0 mg–500.0 mg

SLU-PP-332

SLU-PP332, ERR agonist

Estrogen-related receptor agonism ("exercise mimetic") researched for metabolic and endurance effects.

MetabolicMuscle Building

Half-life: 0.2d
Typical: 5.00 mg–30.0 mg

Vitamin D3

Cholecalciferol, Vitamin D

Immune SupportHormone Support

Cholecalciferol; fat-soluble vitamin important for bone health, immunity, and hormonal balance.

Informational · not plottable

Lemon Bottle (Lipolysis Injection)

Lemon Bottle

Brand-name lipolysis injection combining riboflavin and other lipotropic ingredients for localized fat.

Weight LossSkin Health

Informational · not plottable

LC120 Lipo-C

Lipo-C, LC120

Lipotropic injection of methionine, choline, carnitine, and dexpanthenol used in weight-loss protocols.

Informational · not plottable

LC216 Lipo-B

Lipo-B, LC216

Lipotropic B-complex/MIC injection (carnitine, arginine, methionine, inositol, choline, B6/B5/B12).

Informational · not plottable

LC425 Lipo-C (FOCUS)

Lipo-C FOCUS, LC425

Energy-focused Lipo-C variant (ATP, Eria jarensis, carnitine, MIC, lidocaine) for weight-loss/energy protocols.

Informational · not plottable

LC526 Lipo-C (FAT BLASTER)

Lipo-C FAT BLASTER, LC526

High-strength lipotropic injection (526 mg/mL total: L-carnitine, MIC, B12, B6, NADH) sold for fat-loss clinic protocols.

Informational · not plottable

SUPER SHRED

Super Shred

Multi-ingredient lipotropic/thermogenic blend (carnitine, MIC, ATP, albuterol, B12) for weight-loss protocols.

Informational · not plottable

SHRED

Shred

Standard MIC/B12 lipotropic injection (L-carnitine, B12, B6, inositol, methionine, choline).

Informational · not plottable

Lipo Mino Mix

Lipo Mino, Lipo Mino Mixals

Lipotropic MIC injection with B-complex (B1/B2/B6) and carnitine for weight-loss support.

Informational · not plottable

SUPER Human Blend

Super Human Blend